Foto del docente

Milo Gatti

Ricercatore in Tenure Track L. 79/2022

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: BIOS-11/A Farmacologia

Pubblicazioni

Milo Gatti, Ippazio Cosimo Antonazzo, Igor Diemberger, Fabrizio De Ponti, Emanuel Raschi, Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2021, 28, Article number: 2047487320915663, pp. 983 - 989 [articolo]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of bsis, cutis, and ciais caused by enterobacterales in critically ill adult patients, «INFECTION AND DRUG RESISTANCE», 2021, 14, pp. 2461 - 2498 [articolo]Open Access

Gatti M.; Viaggi B.; Rossolini G.M.; Pea F.; Viale P., An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critically ill adult patients, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2021, na, pp. 1 - 22 [articolo]

Gatti M.; Pea F., Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics, «CLINICAL PHARMACOKINETICS», 2021, 60, pp. 1271 - 1289 [articolo]Open Access

Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F., Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections, «ANTIBIOTICS», 2021, 10, Article number: 1311, pp. 1 - 12 [articolo]Open Access

Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E., Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems, «CLINICAL NUTRITION», 2021, 40, pp. 1176 - 1185 [articolo]

Filippini D.M.; Gatti M.; Di Martino V.; Cavalieri S.; Fusaroli M.; Ardizzoni A.; Raschi E.; Licitra L., Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis, «INTERNATIONAL JOURNAL OF CANCER», 2021, 149, pp. 675 - 683 [articolo]Open Access

Rinaldi, M.; Bartoletti, M.; Ferrarese, A.; Franceschini, E.; Campoli, C.; Coladonato, S.; Pascale, R.; Tedeschi, S.; Gatti, M.; Cricca, M.; Ambretti, S.; Siniscalchi, A.; Morelli, M. C.; Cescon, M.; Cillo, U.; Di Benedetto, F.; Burra, P.; Mussini, C.; Cristini, F.; Lewis, R.; Viale, P.; Giannella, M., Breakthrough invasive fungal infection after liver transplantation in patients on targeted antifungal prophylaxis: A prospective multicentre study, «TRANSPLANT INFECTIOUS DISEASE», 2021, 23, Article number: e13608, pp. 1 - 9 [articolo]Open Access

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access

Gatti M.; Rinaldi M.; Ferraro G.; Toschi A.; Caroccia N.; Arbizzani F.; Raschi E.; Poluzzi E.; Pea F.; Viale P.; Giannella M., Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis, «MYCOSES», 2021, 64, pp. 1317 - 1327 [articolo]Open Access

Gatti, Milo; Giannella, Maddalena; Raschi, Emanuel; Viale, Pierluigi; De Ponti, Fabrizio, Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2021, 76, pp. 199 - 205 [articolo]

Gatti M.; De Ponti F.; Pea F., Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies, «CNS DRUGS», 2021, 35, pp. 345 - 384 [articolo]Open Access

Gatti, Milo; Pea, Federico, Continuous versus intermittent infusion of antibiotics in Gram-negative multidrug-resistant infections, «CURRENT OPINION IN INFECTIOUS DISEASES», 2021, 34, pp. 737 - 747 [articolo]Open Access

Fusaroli M.; Raschi E.; Gatti M.; De Ponti F.; Poluzzi E., Development of a Network-Based Signal Detection Tool: The COVID-19 Adversome in the FDA Adverse Event Reporting System, «FRONTIERS IN PHARMACOLOGY», 2021, 12, Article number: 740707, pp. 1 - 11 [articolo]Open Access

Gatti M.; De Ponti F., Drug Interactions with Contraceptives, in: Trends in Andrology and Sexual Medicine, Berlino, Springer Science and Business Media Deutschland GmbH, 2021, pp. 325 - 359 (TRENDS IN ANDROLOGY AND SEXUAL MEDICINE) [capitolo di libro]